Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "B02BX" (71)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Other Systemic Hemostatics (B02BX) 4 products
WHO-DDD
L
IP
CI
Alhemo 60 mg/1.5 ml
4223.28
4374.15
10 %
Injektionslösung im Fertigpen: Concizumabum 40mg / 1ml
Novo Nordisk Pharma AG
A / SL
FB
G
L
IP
CI
Alhemo 150 mg/1.5 ml
10558.20
10873.75
10 %
Injektionslösung im Fertigpen: Concizumabum 100mg / 1ml
Novo Nordisk Pharma AG
A / SL
FB
G
IP
CI
Alhemo 15 mg/1.5 ml
k.A.
Injektionslösung im Fertigpen: Concizumabum 10mg / 1ml
Novo Nordisk Pharma AG
A
FB
G
IP
CI
Alhemo 300 mg/3 ml
k.A.
Injektionslösung im Fertigpen: Concizumabum 100mg / 1ml
Novo Nordisk Pharma AG
A
FB
G
Etamsylate (B02BX01) 4 products
WHO-DDD
IP
CI
Dicynone 250
4 ampoule(s)
4.16
13.75
10 %
Injection solution: Etamsylatum 250 mg
OM Pharma SA
B / SL
FB
G
IP
CI
Dicynone 250
100 ampoule(s)
208.05
k.A.
Injection solution: Etamsylatum 250 mg
OM Pharma SA
B
FB
G
IP
CI
Dicynone 500
20 Capsule(s)
k.A.
Capsules: Etamsylatum 500 mg
OM Pharma SA
B
FB
G
IP
CI
Dicynone 500
60 Capsule(s)
k.A.
Capsules: Etamsylatum 500 mg
OM Pharma SA
B
FB
G
Romiplostim (B02BX04) 3 products
WHO-DDD
DrugBank.ca
L
IP
Nplate 125 mcg
223.68
259.70
10 %
Dry substance: Romiplostimum 125 µg
Amgen Switzerland AG
A / SL
FB
G
L
IP
CI
Nplate
Set(s)
447.36
502.95
10 %
mcg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung: Romiplostimum 250 µg
Amgen Switzerland AG
A / SL
FB
G
L
IP
CI
Nplate
Set(s)
894.73
989.50
10 %
mcg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung: Romiplostimum 500 µg
Amgen Switzerland AG
A / SL
FB
G
Eltrombopag (B02BX05) 50 products
WHO-DDD
DrugBank.ca
L
IP
CI
Revolade 12,5 mg
14
194.92
220.10
20 %
Coated tablets: Eltrombopagum 12.5 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 25 mg
14 Tablet(s)
389.83
431.75
20 %
Coated tablets: Eltrombopagum 25 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 25 mg
28 Tablet(s)
779.67
847.05
20 %
Coated tablets: Eltrombopagum 25 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 50 mg
14 Tablet(s)
779.67
847.05
20 %
Coated tablets: Eltrombopagum 50 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 50 mg
28 Tablet(s)
1559.34
1677.75
20 %
Coated tablets: Eltrombopagum 50 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 75 mg
28
2339.01
2508.40
20 %
Coated tablets: Eltrombopagum 75 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Eltrombopag Accord 12.5 mg
14
97.08
121.75
10 %
Coated tablets: Eltrombopagum 12.5 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Accord 25 mg
14
194.15
230.95
10 %
Coated tablets: Eltrombopagum 25 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Accord 25 mg
28
388.30
445.55
10 %
Coated tablets: Eltrombopagum 25 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Accord 50 mg
14
388.30
445.55
10 %
Coated tablets: Eltrombopagum 50 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Accord 50 mg
28
776.61
874.65
10 %
Coated tablets: Eltrombopagum 50 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Accord 75 mg
28
1164.91
1303.75
10 %
Coated tablets: Eltrombopagum 75 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Devatis 12,5 mg
14
67.37
91.25
10 %
Coated tablets: Eltrombopagum 12.5 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Devatis 25 mg
14
134.74
170.00
10 %
Coated tablets: Eltrombopagum 25 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Devatis 25 mg
28
269.44
323.60
10 %
Coated tablets: Eltrombopagum 25 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Devatis 50 mg
14
269.44
323.60
10 %
Coated tablets: Eltrombopagum 50 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Devatis 50 mg
28
538.88
630.75
10 %
Coated tablets: Eltrombopagum 50 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Devatis 75 mg
28
808.32
937.90
10 %
Coated tablets: Eltrombopagum 75 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag NOBEL 12.5 mg
14
97.08
121.75
10 %
Coated tablets: Eltrombopagum 12.5 mg
NOBEL Pharma Schweiz AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag NOBEL 25 mg
14
194.15
230.95
10 %
Coated tablets: Eltrombopagum 25 mg
NOBEL Pharma Schweiz AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag NOBEL 25 mg
28
388.30
445.55
10 %
Coated tablets: Eltrombopagum 25 mg
NOBEL Pharma Schweiz AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag NOBEL 50 mg
14
388.30
445.55
10 %
Coated tablets: Eltrombopagum 50 mg
NOBEL Pharma Schweiz AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag NOBEL 50 mg
28
776.61
874.65
10 %
Coated tablets: Eltrombopagum 50 mg
NOBEL Pharma Schweiz AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag NOBEL 75 mg
28
1164.91
1303.75
10 %
Coated tablets: Eltrombopagum 75 mg
NOBEL Pharma Schweiz AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Spirig HC 25 mg
7
97.08
122.00
10 %
Coated tablets: Eltrombopagum 25 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Spirig HC 25 mg
14
194.15
230.95
10 %
Coated tablets: Eltrombopagum 25 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Spirig HC 25 mg
28
388.30
445.55
10 %
Coated tablets: Eltrombopagum 25 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Spirig HC 50 mg
14
388.30
445.55
10 %
Coated tablets: Eltrombopagum 50 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Spirig HC 50 mg
28
776.61
874.65
10 %
Coated tablets: Eltrombopagum 50 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Spirig HC 75 mg
28
1164.91
1303.75
10 %
Coated tablets: Eltrombopagum 75 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Zentiva 12,5 mg
14
74.85
99.05
10 %
Coated tablets: Eltrombopagum 12.5 mg
Helvepharm AG
●
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Zentiva 25 mg
14
149.69
185.35
10 %
Coated tablets: Eltrombopagum 25 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Zentiva 25 mg
28
299.38
354.30
10 %
Coated tablets: Eltrombopagum 25 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Zentiva 50 mg
14
299.38
354.30
10 %
Coated tablets: Eltrombopagum 50 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Zentiva 50 mg
28
598.76
692.20
10 %
Coated tablets: Eltrombopagum 50 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag Zentiva 75 mg
28
898.14
1030.05
10 %
Coated tablets: Eltrombopagum 75 mg
Helvepharm AG
●
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 25 mg
14
194.15
230.95
10 %
Coated tablets: Eltrombopagum 25 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 25 mg
28
388.30
445.55
10 %
Coated tablets: Eltrombopagum 25 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 50 mg
14
388.30
445.55
10 %
Coated tablets: Eltrombopagum 50 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 50 mg
28
776.60
874.65
10 %
Coated tablets: Eltrombopagum 50 mg
Mepha Pharma AG
●
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 75 mg
28
1164.90
1303.75
10 %
Coated tablets: Eltrombopagum 75 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Eltrombopag Leman 25 mg
14
k.A.
Coated tablets: Eltrombopagum 25 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 25 mg
28
k.A.
Coated tablets: Eltrombopagum 25 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 50 mg
14
k.A.
Coated tablets: Eltrombopagum 50 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 50 mg
28
k.A.
Coated tablets: Eltrombopagum 50 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 75 mg
28
k.A.
Coated tablets: Eltrombopagum 75 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 25 mg
84
k.A.
Coated tablets: Eltrombopagum 25 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 50 mg
84
k.A.
Coated tablets: Eltrombopagum 50 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 75 mg
14
k.A.
Coated tablets: Eltrombopagum 75 mg
Leman SKL SA
A
FB
G
IP
CI
Eltrombopag Leman 75 mg
84
k.A.
Coated tablets: Eltrombopagum 75 mg
Leman SKL SA
A
FB
G
Emicizumab (B02BX06) 6 products
WHO-DDD
L
IP
CI
Hemlibra 30mg/1ml
1599.97
1682.60
10 %
Injection solution: Emicizumabum 30 mg/ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 12mg/0.4ml
639.99
697.65
10 %
Injection solution: Emicizumabum 12mg / 0.4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 60mg/0.4ml
3199.94
3324.20
10 %
Injection solution: Emicizumabum 60mg / 0.4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 105mg/0.7ml
5599.90
5786.55
10 %
Injection solution: Emicizumabum 105mg / 0.7ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 150mg/1ml
7999.86
8248.90
10 %
Injection solution: Emicizumabum 150 mg/ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 300mg/2ml
15999.72
16456.75
10 %
Injection solution: Emicizumabum 300mg / 2ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Avatrombopag (B02BX08) 3 products
WHO-DDD
L
IP
Doptelet 20 mg
10
620.37
691.10
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
Doptelet 20 mg
15
930.56
1028.45
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
Doptelet 20 mg
30
1861.11
2040.50
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
Marstacimab (B02BX11) 1 products
WHO-DDD
L
IP
CI
Hympavzi 150 mg
6669.64
6884.10
10 %
Injektionslösung im Fertigpen: Marstacimabum 150 mg/ml
Pfizer AG
A / SL
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
